Evaluation of genotoxic effects of oral exposure to Aluminum oxide nanomaterials in rat bone marrow

• Published in: Mutation research. Genetic toxicology and environmental mutagenesis 2009-05, Vol.676 (1), p.41-47
• Main Authors: Balasubramanyam, A., Sailaja, N., Mahboob, M., Rahman, M.F., Misra, S., Hussain, Saber M., Grover, Paramjit
• Format: Article
• Language: English
• Subjects: Aluminum oxide; Biological and medical sciences; Chromosomal aberrations assay; Fundamental and applied biological sciences. Psychology; Genetics of eukaryotes. Biological and molecular evolution; Genotoxicity; Medical sciences; Micronucleus test; Nanomaterials; Rat; Toxicology
• ISSN: 1383-5718; 1879-3592
• DOI: 10.1016/j.mrgentox.2009.03.004

Nanomaterials have novel properties and functions because of their small size. The unique nature of nanomaterials may be associated with potentially toxic effects. The aim of this study was to evaluate the in vivo genotoxicity of rats exposed with Aluminum oxide nanomaterials. Hence in the present study, the genotoxicity of Aluminum oxide nanomaterials (30 and 40 nm) and its bulk material was studied in bone marrow of female Wistar rats using chromosomal aberration and micronucleus assays. The rats were administered orally with the doses of 500, 1000 and 2000 mg/kg bw. Statistically significant genotoxicity was observed with Aluminum oxide 30 and 40 nm with micronucleus as well as chromosomal aberration assays. Significantly ( p < 0.05 or p < 0.001) increased frequency of MN was observed with 1000 and 2000 mg/kg bw dose levels of Aluminum oxide 30 nm (9.4 ± 1.87 and 15.2 ± 2.3, respectively) and Aluminum oxide 40 nm (8.1 ± 1.8 and 13.9 ± 2.21, respectively) over control (2.5 ± 0.7) at 30 h. Likewise, at 48 h sampling time a significant ( p < 0.05 or p < 0.001) increase in frequency of MN was evident at 1000 and 2000 mg/kg bw dose levels of Aluminum oxide 30 nm (10.6 ± 1.68 and 16.6 ± 2.66, respectively) and Aluminum oxide 40 nm (9.0 ± 1.38 and 14.7 ± 1.68, respectively) compared to control (1.8 ± 0.75). Significantly increased frequencies ( p < 0.05 or p < 0.001) of chromosomal aberrations were observed with Aluminum oxide 30 nm (1000 and 2000 mg/kg bw) and Aluminum oxide 40 nm (2000 mg/kg bw) in comparison to control at 18 and 24 h. Further, since there is need for information on the toxicokinetics of nanomaterials, determination of these properties of the nanomaterials was carried out in different tissues, urine and feces using inductively coupled plasma mass spectrometry (ICP–MS). A significant size dependent accumulation of Aluminum oxide nanomaterials occurred in different tissues, urine and feces of rats as shown by ICP–MS data. The results of our study suggest that exposure to Aluminum oxide nanomaterials has the potential to cause genetic damage.